Tandem als eerste klinische AI-platform in Europa met drie onafhankelijk MDR Klasse IIa-gecertificeerde producten
Source: Emerce.nl· Tandem Health· July 28, 2026
SynaBot summary
Tandem Health secured European regulatory approval for three AI-powered clinical decision support tools. This makes it the first AI platform in Europe to achieve this MDR Class IIa certification, signifying a significant step for AI in healthcare.
Key takeaways
- European AI healthcare platform gains MDR Class IIa certification.
- First AI clinical decision support system certified in Europe.
- Regulatory approval validates AI's role in medical diagnostics.
- Opens doors for more AI adoption in European healthcare.
Why it matters
This development signals increased regulatory acceptance of AI in critical healthcare applications. For professionals using AI tools, it suggests a future with more validated and trustworthy AI assistants available for complex tasks, potentially improving diagnostic accuracy and patient care.
This story was reported by Emerce.nl. Read the full original article:
Read on Emerce.nl 
